Top

Published in:

01-03-2018 | Review

The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review

Authors: Kayla B. Stefanidis, Christopher D. Askew, Kim Greaves, Mathew J. Summers

Published in: Neuropsychology Review | Issue 1/2018

Abstract

Cardiovascular disease is associated with increased risk for cognitive decline and dementia, but it is unclear whether this risk varies across disease states or occurs in the absence of symptomatic stroke. To examine the evidence of increased risk for cognitive decline and dementia following non-stroke cardiovascular disease we conducted two independent meta-analyses in accordance with PRISMA guidelines. The first review examined cardiovascular diagnoses (atrial fibrillation, congestive heart failure, periphery artery disease and myocardial infarction) while the second review assessed the impact of atherosclerotic burden (as indicated by degree of stenosis, calcification score, plaque morphology or number of plaques). Studies eligible for review longitudinally assessed risk for clinically significant cognitive decline and/or dementia and excluded stroke and cognitive impairment at baseline. Summary statistics were computed via the inverse variance weighted method, utilising Cox Proportional Hazards data (Hazard Ratios, HR). Both atrial fibrillation (n = 5, HR = 1.26, 95% CI [1.12, 1.43]) and severe atherosclerosis (n = 4, HR = 1.59, 95% CI [1.12, 2.26]) emerged as significant risk factors for cognitive decline and/or dementia. A small set of studies reviewed, insufficient for meta-analysis, examining congestive heart failure, peripheral artery disease and myocardial infarction suggested that these conditions may also be associated with an increased risk of cognitive decline/dementia. In the absence of stroke, patients with atrial fibrillation or generalised atherosclerosis are at heightened risk for cognitive deterioration. Nonetheless, this paper highlights the need for methodologically rigorous and prospective investigation of the relationship between CVD and dementia.

Available only for authorised users

Alonso, A., Jacobs, D. R., Menotti, A., Nissinen, A., Dontas, A., Kafatos, A., & Kromhout, D. (2009). Cardiovascular risk factors and dementia mortality: 40 years of follow-up in the Seven Countries Study. Journal of the Neurological Sciences, 280, 79–83. doi:https://doi.org/10.1016/j.jns.2009.02.004.CrossRefPubMed

Anstey, K. J., Cherbuin, N., Budge, M., & Young, J. (2011). Body mass index in midlife and late-life as a risk factor for dementia: A meta-analysis of prospective studies. Obesity Reviews, 12, e426–e437. doi:https://doi.org/10.1111/j.1467-789X.2010.00825.x.CrossRefPubMed

Anstey, K. J., von Sanden, C., Salim, A., & O'Kearney, R. (2007). Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. American Journal of Epidemiology, 166, 367–378. doi:https://doi.org/10.1093/aje/kwm116.CrossRefPubMed

Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009). Introduction to meta-analysis. Chichester: John Wiley & Sons.CrossRef

*Bos, D., Vernooij, M. W., de Bruijn, R. F. A. G., Koudstaal, P. J., Hofman, A., Franco, O. H., et al. (2015). Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline. Alzheimer's & Dementia, 11, 639–647. doi:https://doi.org/10.1016/j.jalz.2014.05.1758.CrossRef

*Carcaillon, L., Plichart, M., Zureik, M., Rouaud, O., Majed, B., Ritchie, K., et al. (2015). Carotid plaque as a predictor of dementia in older adults: The Three-City Study. Alzheimer's & Dementia, 11, 239–248. doi:https://doi.org/10.1016/j.jalz.2014.07.160.CrossRef

Cohen, R. A. (2010). Neuropsychology of heart disease: Levels of analysis. In R. A. Cohen & J. Gunstad (Eds.), Neuropsychology and cardiovascular disease (pp. 19–29). New York: Oxford University Press.

*de Bruijn, R. F. A. G., Heeringa, J., Wolters, F. J., Franco, O. H., Stricker, B. H., Hofman, A., et al. (2015). Association between atrial fibrillation and dementia in the general population. JAMA Neurology, 72, 1288–1294. doi:https://doi.org/10.1001/jamaneurol.2015.2161.CrossRefPubMed

de la Torre, J. C. (2012). Cardiovascular risk factors promote Brain hypoperfusion leading to cognitive decline and dementia. Cardiovascular Psychiatry and Neurology, 2012, 367516. doi:https://doi.org/10.1155/2012/367516.PubMedPubMedCentral

Debette, S., Bauters, C., Leys, D., Lamblin, N., Pasquier, F., & de Groote, P. (2007). Prevalence and determinants of cognitive impairment in chronic heart failure patients. Congestive Heart Failure, 13, 205–208. doi:https://doi.org/10.1111/j.1527-5299.2007.06612.x.CrossRefPubMed

*Dublin, S., Anderson, M. L., Haneuse, S. J., Heckbert, S. R., Crane, P. K., Breitner, J. C., et al. (2011). Atrial fibrillation and risk of dementia: A prospective cohort study. Journal of the American Geriatrics Society, 59, 1369–1375. doi:https://doi.org/10.1111/j.1532-5415.2011.03508.x.CrossRefPubMedPubMedCentral

Elias, M. F., Sullivan, L. M., Elias, P. K., Vasan, R. S., D'Agostino Sr., R. B., Seshadri, S., et al. (2006). Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men. Journal of Stroke and Cerebrovascular Diseases, 15, 214–222. doi:https://doi.org/10.1016/j.jstrokecerebrovasdis.2006.05.009.CrossRefPubMed

Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008). Cardiovascular risk factors and dementia. The American Journal of Geriatric Pharmacotherapy, 6, 100–118. doi:https://doi.org/10.1016/j.amjopharm.2008.06.004.CrossRefPubMed

Flück, D., Beaudin, A. E., Steinback, C. D., Kumarpillai, G., Shobha, N., McCreary, C. R., et al. (2014). Effects of aging on the association between cerebrovascular responses to visual stimulation, hypercapnia and arterial stiffness. Frontiers in Physiology, 5. doi:https://doi.org/10.3389/fphys.2014.00049.

*Haring, B., Leng, X., Robinson, J., Johnson, K. C., Jackson, R. D., Beyth, R., et al. (2013). Cardiovascular disease and cognitive decline in postmenopausal women: Results from the Women's Health Initiative Memory Study. Journal of the American Heart Association, 2, e000369. doi:https://doi.org/10.1161/jaha.113.000369.CrossRefPubMedPubMedCentral

Higgins, J. P. T., Altman, D. G., Gøtzsche, P. C., Jüni, P., Moher, D., Oxman, A. D., et al. (2011). The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ, 343, d5928. doi:https://doi.org/10.1136/bmj.d5928.CrossRefPubMedPubMedCentral

Hofman, A., Ott, A., Breteler, M. M. B., Bots, M. L., Slooter, A. J. C., van Harskamp, F., et al. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. The Lancet, 349, 151–154. doi:https://doi.org/10.1016/S0140-6736(96)09328-2.CrossRef

Jefferson, A. L., Holland, C. M., Tate, D. F., Csapo, I., Poppas, A., Cohen, R. A., & Guttmann, C. R. G. (2011). Atlas-derived perfusion correlates of white matter hyperintensities in patients with reduced cardiac output. Neurobiology of Aging, 32, 133–139. doi:https://doi.org/10.1016/j.neurobiolaging.2009.01.011.CrossRefPubMed

Jozwiak, A., Guzik, P., Mathew, A., Wykretowicz, A., & Wysocki, H. (2006). Association of atrial fibrillation and focal neurologic deficits with impaired cognitive function in hospitalized patients ≥65 years of age. The American Journal of Cardiology, 98, 1238–1241. doi:https://doi.org/10.1016/j.amjcard.2006.05.058.CrossRefPubMed

Kalantarian, S., Stern, T. A., Mansour, M., & Ruskin, J. N. (2013). Cognitive impairment associated with atrial fibrillation: A meta-analysis. Annals of Internal Medicine, 158, 338–346. doi:https://doi.org/10.7326/0003-4819-158-5-201303050-00007.CrossRefPubMedPubMedCentral

Kawabata-Yoshihara, L. A., Scazufca, M., Santos Ide, S., Whitaker, A., Kawabata, V. S., Benseñor, I. M., et al. (2012). Atrial fibrillation and dementia: Results from the Sao Paulo Ageing & Health study. Arquivos Brasileiros de Cardiologia, 99, 1108–1114.CrossRefPubMed

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., et al. (2002). Apolipoprotein E ε4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Annals of Internal Medicine, 137, 149–155. doi:https://doi.org/10.7326/0003-4819-137-3-200208060-00006.CrossRefPubMed

Knecht, S., Oelschläger, C., Duning, T., Lohmann, H., Albers, J., Stehling, C., et al. (2008). Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. European Heart Journal, 29, 2125–2132. doi:https://doi.org/10.1093/eurheartj/ehn341.CrossRefPubMed

Kwok, C. S., Loke, Y. K., Hale, R., Potter, J. F., & Myint, P. K. (2011). Atrial fibrillation and incidence of dementia: A systematic review and meta-analysis. Neurology, 76, 914–922. doi:https://doi.org/10.1212/WNL.0b013e31820f2e38.CrossRefPubMed

Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006). The case of the misleading funnel plot. BMJ, 333(7568), 597–600. doi:https://doi.org/10.1136/bmj.333.7568.597.CrossRefPubMedPubMedCentral

Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., et al. (2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6, e1000100. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00136.CrossRefPubMedPubMedCentral

Llewellyn, D. J., Lang, I. A., Matthews, F. E., Plassman, B. L., Rogers, M. A., Morgenstern, L. B., et al. (2010). Vascular health, diabetes, APoE and dementia: The Aging, Demographics, and Memory Study. Alzheimer's Research & Therapy, 2, 19. doi:https://doi.org/10.1186/alzrt43.CrossRef

*Marengoni, A., Qiu, C., Winblad, B., & Fratiglioni, L. (2011). Atrial fibrillation, stroke and dementia in the very old: A population-based study. Neurobiology of Aging, 32, 1336–1337. doi:https://doi.org/10.1016/j.neurobiolaging.2009.08.002.CrossRefPubMed

*Marzona, I., O'Donnell, M., Teo, K., Gao, P., Anderson, C., Bosch, J., & Yusuf, S. (2012). Increased risk of cognitive and functional decline in patients with atrial fibrillation: Results of the ONTARGET and TRANSCEND studies. CMAJ, 184, E329–E336. doi:https://doi.org/10.1503/cmaj.111173.CrossRefPubMedPubMedCentral

Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009). Preferred Reporting Items for Systematic reviews and Meta-Analyses: The PRISMA Statement. Annals of Internal Medicine, 151, 264–269. doi:https://doi.org/10.7326/0003-4819-151-4-200908180-00135.CrossRefPubMed

*Newman, A. B., Fitzpatrick, A. L., Lopez, O., Jackson, S., Lyketsos, C., Jagust, W., et al. (2005). Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. Journal of the American Geriatrics Society, 53, 1101–1107. doi:https://doi.org/10.1111/j.1532-5415.2005.53360.x.CrossRefPubMed

Ott, A., Breteler, M. M. B., de Bruyne, M. C., van Harskamp, F., Grobbee, D. E., & Hofman, A. (1997). Atrial fibrillation and dementia in a population-based study: The Rotterdam Study. Stroke, 28, 316–321. doi:https://doi.org/10.1161/01.str.28.2.316.CrossRefPubMed

Pinkston, J. B., Alekseeva, N., & Toledo, E. G. (2009). Stroke and dementia. Neurological Research, 31, 824–831. doi:https://doi.org/10.1179/016164109x12445505689643.CrossRefPubMed

Pressler, S. J., Subramanian, U., Kareken, D., Perkins, S. M., Gradus-Pizlo, I., Sauve, M. J., et al. (2010). Cognitive deficits in chronic heart failure. Nursing Research, 59, 127–139. doi:https://doi.org/10.1097/NNR.0b013e3181d1a747.CrossRefPubMedPubMedCentral

Qiu, C., Winblad, B., Marengoni, A., Klarin, I., Fastbom, J., & Fratiglioni, L. (2006). Heart failure and risk of dementia and alzheimer disease: A population-based cohort study. Archives of Internal Medicine, 166, 1003–1008. doi:https://doi.org/10.1001/archinte.166.9.1003.CrossRefPubMed

Rusanen, M., Kivipelto, M., Levälahti, E., Laatikainen, T., Tuomilehto, J., Soininen, H., & Ngandu, T. (2014). Heart diseases and long-term risk of dementia and Alzheimer's disease: A population-based CAIDE study. Journal of Alzheimer's Disease, 42, 183–191. doi:https://doi.org/10.3233/jad-132363.PubMed

Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007). Mixed brain pathologies account for most dementia cases in community-dwelling older persons. Neurology, 69, 2197–2204. doi:https://doi.org/10.1212/01.wnl.0000271090.28148.24.CrossRefPubMed

Schwarzer, G. (2007). ‘meta’: An R package for meta-analysis: R News, 7, 40–45. https://cran.r-project.org/doc/Rnews/Rnews_2007-3.pdf.

Silbert, B. S., Scott, D. A., Evered, L. A., Lewis, M. S., & Maruff, P. T. (2007). Preexisting cognitive impairment in patients scheduled for elective coronary artery bypass graft surgery. Anesthesia & Analgesia, 104, 1023–1028. doi:https://doi.org/10.1213/01.ane.0000263285.03361.3a.CrossRef

Tierney, J. F., Stewart, L. A., Ghersi, D., Burdett, S., & Sydes, M. R. (2007). Practical methods for incorporating summary time-to-event data into meta-analysis. [journal article]. Trials, 8, 1–16. doi:https://doi.org/10.1186/1745-6215-8-16.CrossRef

Waldstein, S. R., Tankard, C. F., Maier, K. J., Pelletier, J. R., Snow, J., Gardner, A. W., et al. (2003). Peripheral arterial disease and cognitive function. Psychosomatic Medicine, 65, 757–763.CrossRefPubMed

*Wendell, C. R., Waldstein, S. R., Ferrucci, L., O'Brien, R. J., Strait, J. B., & Zonderman, A. B. (2012). Carotid atherosclerosis and prospective risk of dementia. Stroke, 43, 3319–3324. doi:https://doi.org/10.1161/strokeaha.112.672527.CrossRefPubMedPubMedCentral

Xiang, J., Zhang, T., Yang, Q.-W., Liu, J., Chen, Y., Cui, M., et al. (2013). Carotid artery atherosclerosis is correlated with cognitive impairment in an elderly urban Chinese non-stroke population. Journal of Clinical Neuroscience, 20, 1571–1575. doi:https://doi.org/10.1016/j.jocn.2013.02.026.CrossRefPubMed

Title: The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review
Authors: Kayla B. Stefanidis
Christopher D. Askew
Kim Greaves
Mathew J. Summers
Publication date: 01-03-2018
Publisher: Springer US
Published in: Neuropsychology Review / Issue 1/2018
Print ISSN: 1040-7308
Electronic ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-017-9359-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Effect of Non-Stroke Cardiovascular Disease States on Risk for Cognitive Decline and Dementia: A Systematic and Meta-Analytic Review

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2018

Fatigue following Paediatric Acquired Brain Injury and its Impact on Functional Outcomes: A Systematic Review

Prosaccade and Antisaccade Paradigms in Persons with Alzheimer’s Disease: A Meta-Analytic Review

Memory Rehabilitation in Patients with Epilepsy: a Systematic Review

A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples

Meta-Analysis of Intelligence Quotient (IQ) in Obsessive-Compulsive Disorder

Reviewer Acknowledgement